TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)

Historical Holders from Q1 2019 to Q1 2025

Symbol
TMCI on Nasdaq
CUSIP
89455T109
Type / Class
Equity / Common stock, $0.001 par value
Shares outstanding
62.3M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
37.3M
Holdings value
$278M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
133
Number of buys
62
Number of sells
-66
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 9.97% $52.1M 6.21M Armistice Capital, LLC Dec 31, 2024
MORGAN STANLEY 3.4% $17.6M 2.09M Morgan Stanley Dec 31, 2024

Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 335K $2.81M -$128K $8.39 11
2024 Q4 37.3M $278M -$12.7M $7.44 133
2024 Q3 39.2M $228M +$79.7K $5.80 132
2024 Q2 39.7M $264M -$72.8M $6.65 126
2024 Q1 40.8M $532M -$2.99M $13.05 127
2023 Q4 40.9M $522M -$5.31M $12.75 125
2023 Q3 38.3M $502M -$36.8M $13.11 123
2023 Q2 38.1M $973M +$63M $25.58 134
2023 Q1 35.5M $895M +$184M $25.19 121
2022 Q4 26.9M $617M +$44M $22.99 103
2022 Q3 26.1M $576M +$73.5M $22.07 89
2022 Q2 23.1M $331M +$38.3M $14.34 79
2022 Q1 20.4M $385M -$167M $18.91 75
2021 Q4 17.2M $321M +$67M $18.64 75
2021 Q3 13M $351M -$6.97M $26.90 62
2021 Q2 13M $407M +$407M $31.26 70
2021 Q1 179 $6K $0 $33.52 1
2020 Q4 179 $6K $0 $33.52 1
2020 Q3 179 $6K $0 $33.52 1
2020 Q2 179 $6K $0 $33.52 1
2020 Q1 179 $6K $0 $33.52 1
2019 Q4 179 $6K $0 $33.52 1
2019 Q3 179 $6K $0 $33.52 1
2019 Q2 179 $6K $0 $33.52 1
2019 Q1 179 $6K $0 $33.52 1